(Press-News.org) Breast cancer is the most diagnosed cancer among U.S. women and the second leading cause of cancer death. Black women who develop breast cancer are around 40% more likely to die of the disease than white women, but it was unclear until now whether this disparity exists across all types of breast cancer. Now, a meta-analysis led by Mass General Brigham researchers shows that Black women have a higher risk of dying from breast cancer for all tumor subtypes, and the size of this disparity varies from 17-50% depending on the type of breast cancer.
These findings, published in the Journal of Clinical Oncology, demonstrate that higher mortality rates among Black women with breast cancer are at least partially attributable to factors that are independent of tumor biology—for example, socioeconomic inequality, delays in diagnosis, and inadequate access to timely quality cancer treatment resulting from systemic racism.
“Our findings demonstrate that multiple, interacting factors contribute to disparities in breast cancer survival between Black and white women,” said senior author Erica Warner, ScD, MPH, a cancer epidemiologist at Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system. “To achieve equity, intervention is necessary at multiple levels—from community to healthcare systems and individual healthcare providers, to patients themselves learning about their disease and what their expectations should be for their care.”
Though it is often discussed as a single disease, breast cancer has multiple subtypes that differ in risk factors, treatment, and prognosis. These subtypes are defined based on whether the cancer cells carry hormone receptors for estrogen or progesterone, which can be targeted for treatment, and whether they carry HER2 (human epidermal growth receptor 2), a protein associated with cancer aggressiveness and another potential treatment target.
“There had been an anecdotal sense in the research community that differences in survival between Black and white women were greater for the most treatable forms of the disease—tumors that carry hormone receptors—and smaller for the historically less-treatable, hormone-negative tumors,” said Warner.
To investigate whether these anecdotes were supported by the evidence, Warner’s team combined data from 18 studies that were published between 2009 and 2022. Altogether, these studies analyzed 228,885 breast cancer cases, 34,262 of which were in Black women.
They found that survival was worse for Black women for all breast cancer subtypes, though the size of these disparities varied between breast cancer subtypes. There was a larger racial disparity for hormone-positive tumors, which were associated with a 34-50% higher risk of death for Black women, compared to hormone-negative tumors, which were associated with a 17-20% higher risk of death for Black women.
“These findings underscore a stark reality in our healthcare system: Black women are facing higher risks of death from breast cancer compared to their white counterparts, across all types of the disease. This disparity isn't just about biology,” said co-author Paulette Chandler, MD, MPH, associate epidemiologist in the Division of Preventive Medicine at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system. “It's a call to action for healthcare providers, policymakers, and communities alike to confront these inequities head-on and strive for meaningful change in breast cancer outcomes.”
Because hormone-negative tumors are less common, Warner says that racial disparities in breast cancer survival for hormone-negative subtypes were likely not observed previously because individual studies lacked statistical power due to the small number of cases.
“There may also be differences in the biological characteristics of some tumor subtypes between racial groups that our therapies are not attuned to, potentially because of underrepresentation of Black women in clinical trials,” said Warner.
However, these racial disparities are not inevitable, and the researchers point to several existing multilevel intervention programs that have successfully reduced disparities in cancer survival. These programs leverage multiple strategies, including helping patients navigate the healthcare system, proactively identifying social needs and connecting patients with resources to address those needs, and by implementing systems that alert healthcare workers of missed appointments or unmet care milestones. At the national level, interventions like ACCURE and Equal Hope aim to close gaps in mortality and survival between Black and white women. Locally, MGH is collaborating with Boston Medical Center on a virtual Equity Hub for Cancer Treatment with the goal of enhancing partnerships and improving cancer care for underserved patients at community-based mental health centers.
Authorship: In addition to Warner, Mass General Brigham authors include Paulette D. Chandler. Additional authors include Juliana M. Torres, Michelle O. Sodipo, Margaret F. Hopkins.
Funding: This research was supported by funding from the National Cancer Institute (R25CA221738, T32CA009001, and K01CA188075).
Paper cited: Torres, J et al. “Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis” Journal of Clinical Oncology DOI: 10.1200/JCO.23.02311
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
In May, a major cyberattack disabled clinical operations for nearly a month at Ascension, a health care provider that includes 140 hospitals across the U.S. Investigators tracked the problem to malicious ransomware that had infected an employee’s computer.
Health care systems offer juicy targets for cybercrime because of the valuable personal, financial, and health data they hold. A 2023 survey of health information technology and IT security professionals reported that 88% of ...
Integral Molecular, a leader in antibody discovery and characterization, has published new research in the journal mAbs, revealing that as many as one-third of antibody-based drugs exhibit nonspecific binding to unintended targets. A serious concern, off-target drug binding is a significant cause of adverse events in patients, with the potential to even cause death. Analysis of antibody off-target binding across different phases of clinical development suggests this to be a major cause of drug attrition. Early specificity testing could improve drug approvals and patient safety.
Learn how antibody developers can use the Membrane Proteome Array™ to assess specificity ...
Reducing the serving size for beer, lager and cider reduces the volume of those drinks consumed in pubs, bars and restaurants, and could be a useful alcohol control measure, according to research published September 17th in the open-access journal PLOS Medicine. Theresa Marteau and colleagues at the University of Cambridge, UK, found that over a short intervention period, venues that removed the pint and offered two third pints instead, sold 10% less beer by volume compared with when pints were available.
When wine by the glass is offered in smaller servings, the amount sold ...
Lower socioeconomic status is associated with higher rates of death from coronary artery disease compared to higher socioeconomic status, and more than half of the disparities can be explained by four unhealthy behaviors. Dr. Yachen Zhu of the Alcohol Research Group, U.S., and Dr. Charlotte Probst of the Centre for Addiction and Mental Health, Canada, report these findings in a new study published September 17th in the open-access journal PLOS Medicine.
Coronary artery disease, also known as coronary heart disease or ischemic heart disease, occurs when the arteries supplying the heart cannot deliver enough oxygen-rich blood due to plaque buildup, and is a major cause of death in the ...
Trachomatous trichiasis, a potentially blinding condition where inward-turned eyelashes scratch the front of the eye, can successfully be treated by either of the two most common types of eyelid surgery, according to findings from a large comparison trial funded by the National Institutes of Health. In light of previous, smaller studies, which suggested that one of the commonly used surgery types had poorer outcomes, this study provides reassurance that either technique can treat the condition. The study, published in PLOS Neglected ...
DETROIT — A grant from the National Institutes of Health will support ongoing research at Wayne State University investigating the consequences environmental factors may have on fertility in males.
The five-year, $3,082,404 grant from the National Institute of Environmental Health Sciences of the National Institutes of Health is led by Richard Pilsner, Ph.D., professor and the Robert J. Sokol, M.D., Endowed Chair of Molecular Obstetrics and Gynecology in the C.S. Mott Center for Human Growth and Development in the department of Obstetrics/Gynecology at Wayne State, and faculty member in the Institute of Environmental ...
WASHINGTON (September 17, 2024) – Children’s National Hospital, widely recognized for its expertise and innovation in pediatric care, has been chosen by the Biomedical Advanced Research and Development Authority (BARDA) to lead the Special Populations Hub in the next generation of the BARDA Accelerator Network. BARDA, is part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).
The next generation of the BARDA Accelerator Network builds on lessons learned from the first iteration of the network ...
Norway introduced its Regular GP Scheme was introduced in 2001. This gave all citizens the right to choose a GP in their home municipality and facilitates personal continuity between the doctor and the patient.
These types of long-term doctor-patient relationships are associated with reduced use of emergency health services and lower mortality, both internationally and in Norway.
A widely discussed Norwegian study from 2022 showed that patients who had the same GP for more than fifteen years had a 25 per cent lower risk of dying compared to patients who had the same GP for one year or less.
However, there has been an increasing shortage of GPs in recent years. As of July 2024, just over ...
Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body’s defenses can swoop in, destroying rogue cells before they can do much damage. Lying at the heart of this early warning system are lipids, fatty compounds previously seen by cancer biologists primarily as a fuel source for burgeoning tumors.
But now, a new study in Nature demonstrates that one particular lipid type is actually ...
The spacecraft bus that will deliver NASA’s Nancy Grace Roman Space Telescope to its orbit and enable it to function once there is now complete after years of construction, installation, and testing.
Now that the spacecraft is assembled, engineers will begin working to integrate the observatory’s other major components, including the science instruments and the telescope itself.
“They call it a spacecraft bus for a reason — it gets the telescope to where it needs to be ...
